Millennium Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,645
| Closed | -$118K | – | 7312 |
|
|
2022
Q4 | $118K | Buy |
18,645
+6,546
| +54% | +$36.2K | ﹤0.01% | 5524 |
|
|
2022
Q3 | $62K | Buy |
+12,099
| New | +$76K | ﹤0.01% | 6115 |
|
|
2022
Q2 | – | Sell |
-85,834
| Closed | -$305K | – | 7762 |
|
|
2022
Q1 | $305K | Buy |
85,834
+40,514
| +89% | +$150K | ﹤0.01% | 5524 |
|
|
2021
Q4 | $228K | Buy |
45,320
+29,773
| +192% | +$180K | ﹤0.01% | 5797 |
|
|
2021
Q3 | $114K | Buy |
+15,547
| New | +$107K | ﹤0.01% | 6380 |
|
|
2020
Q2 | – | Sell |
-3,047
| Closed | -$11K | – | 4757 |
|
|
2020
Q1 | $11K | Sell |
3,047
-10,470
| -77% | -$54.2K | ﹤0.01% | 3758 |
|
|
2019
Q4 | $85K | Sell |
13,517
-11,502
| -46% | -$146K | ﹤0.01% | 4047 |
|
|
2019
Q3 | $350K | Sell |
25,019
-28,278
| -53% | -$466K | ﹤0.01% | 3477 |
|
|
2019
Q2 | $787K | Buy |
+53,297
| New | +$1.43M | ﹤0.01% | 2950 |
|
|
2018
Q2 | – | Sell |
-22,916
| Closed | -$1.41M | – | 4306 |
|
|
2018
Q1 | $1.41M | Buy |
22,916
+10,343
| +82% | +$546K | ﹤0.01% | 2523 |
|
|
2017
Q4 | $676K | Buy |
+12,573
| New | +$748K | ﹤0.01% | 2945 |
|
|
2017
Q3 | – | Sell |
-12,499
| Closed | -$677K | – | 3981 |
|
|
2017
Q2 | $677K | Sell |
12,499
-3,755
| -23% | -$174K | ﹤0.01% | 2646 |
|
|
2017
Q1 | $579K | Buy |
+16,254
| New | +$557K | ﹤0.01% | 2738 |
|
Millennium Management's FSTX Position: Q1 2023 in Review
Millennium Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 18,645 shares — an estimated $118K sold.
Millennium Management first reported a position in FSTX in Q1 2017 and held it in 13 quarters. The position peaked at $1.41M in Q1 2018. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.
- Millennium Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Millennium Management sold 18,645 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $118K.
- Millennium Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2017 and held it in 13 quarters.
- Millennium Management's F-star Therapeutics, Inc. Common Stock position peaked at $1.41M in Q1 2018.
- 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.